This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Innovator Constanze Scherer: Pioneering Advances in Potassium Channel Research
Introduction
Constanze Scherer is a notable inventor based in Tübingen, Germany. She has made significant contributions to the field of molecular biology, particularly in the study of potassium channels. Her work has implications for understanding various physiological processes and potential therapeutic applications.
Latest Patents
Constanze Scherer holds a patent for a nucleic acid molecule encoding the potassium channel protein, KCNQ5. This patent describes DNA encoding KCNQ5 or a polypeptide having KCNQ5 activity, along with related vectors, host cells, and methods. Additionally, it includes a screening assay for the identification of compounds that modify the activity of the potassium channel KCNQ5. This innovation is crucial for advancing research in ion channel functionality and drug discovery.
Career Highlights
Constanze Scherer is currently employed at Aventis Pharma Deutschland GmbH, where she continues her research and development efforts. Her work at this prominent pharmaceutical company allows her to collaborate with other experts in the field and contribute to groundbreaking advancements in medical science.
Collaborations
Throughout her career, Constanze has worked alongside esteemed colleagues such as Klaus Steinmeyer and Christian Lerche. These collaborations have fostered a productive environment for innovation and have led to significant advancements in their shared research interests.
Conclusion
Constanze Scherer is a pioneering inventor whose work on potassium channels has the potential to impact various medical fields. Her contributions to science and collaboration with other experts highlight her importance in the realm of molecular biology.